Skip to main content
SpringerLink
Log in

Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background

Non-functioning (NF) pancreatic neuroendocrine tumors (pNET) often have an indolent outcome. A consensus to submit patients with large (>2 cm) NF-pNET to surgery already exists; but a conservative approach for small (≤2 cm) NF neoplasms has been proposed.

Aim

To identify prognostic factors for survival and progression free survival (PFS) of NF-pNET, evaluating whether surgery may be avoided for small NF-pNET.

Subjects and methods

Retrospective study of 77 consecutive patients with pNET submitted to surgery, of which 60 were NF. Pathological tissues were revised according to the 2000 and 2010 WHO classifications. Risk factors for survival and PFS were evaluated using the Kaplan–Meier method and the Cox regression model.

Results

The 8-year cause-specific survival of NF-pNET was 79.3 %. At univariate analysis, high grading, high staging, large tumors, angioinvasion and peri-pancreatic infiltration were significantly associated with a shorter survival; at multivariate analysis only peri-pancreatic infiltration was significantly associated with a shorter NF-pNET survival. Most small NF-pNET were grade 1 (74 %), compared to large NF-pNET (27 %). Distant metastases were present in 29.7 % (n = 11) and 17.4 % (n = 4) of patients with large or small NF-pNET, respectively; among the 19 small NF-pNET without metastasis, five had a local malignancy (lymph node metastasis or local infiltration); thus, 39 % of the 23 NF-pNET, turned out to have a malignant potential.

Conclusions

Among NF-pNET, large neoplasms were associated with worse outcomes; however, small NF-pNET do not seem to have an invariable benign behavior. Whether surgery should be avoided in all patients with small NF-pNET is questionable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Capelli P, Martignoni G, Pedica F et al (2009) Endocrine neoplasms of the pancreas: pathological and genetic features. Arch Pathol Lab Med 133:350–364

    PubMed  Google Scholar 

  2. Solcia E, Kloppel G, Sobin LH (2000) Histological typing of endocrine tumours. Springer-Verlag, New York

    Book  Google Scholar 

  3. Hruban RH, Bishop Pitman M, Klimstra DSL. (2007) Endocrine Neoplasms. Silverberg SG, Sobin LH (eds). Tumors of the pancreas. ARP AFIP: Washington, pp 251–304

  4. Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27

    Article  PubMed  Google Scholar 

  5. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Eriksson B et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Pape UF, Jann H, Müller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265

    Article  PubMed  Google Scholar 

  7. Bettini R, Boninsegna L, Mantovani W et al (2008) Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 19:903–908

    Article  CAS  PubMed  Google Scholar 

  8. Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B (2008) Prognostic factors and survival of 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 14:7798–7803

    Article  CAS  PubMed  Google Scholar 

  9. Scarpa A, Mantovani W, Capelli P et al (2010) Pancreatic endocrine tumors: improve TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 23:824–833

    Article  CAS  PubMed  Google Scholar 

  10. La Rosa S, Klersy C, Uccella S et al (2009) Improved histological and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 40:30–40

    Article  PubMed  Google Scholar 

  11. Falconi M, Bartsch DK, Eriksson B et al (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 95:120–134

    Article  CAS  PubMed  Google Scholar 

  12. Hill JS, McPhee JT, McDade TP et al (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 15:741–751

    Article  Google Scholar 

  13. Jensen RT, Cadiot G, Brandi ML et al (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 95:98–119

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Bettini R, Partelli S, Boninsegna L et al (2011) Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumors. Surgery 150:75–82

    Article  PubMed  Google Scholar 

  15. Falconi M, Zerbi A, Crippa S et al (2010) Parenchyma- preserving resections for small non-functioning pancreatic endocrine tumors. Ann Surg Oncol 17:1621–1627

    Article  PubMed  Google Scholar 

  16. O’Toole D, Grossman A, Gross D et al (2009) ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. Neuroendocrinology 90:194–202

    Article  PubMed  Google Scholar 

  17. Mak PHCR, Irwin MG, American Society of Anesthesiologists (2002) The ASA physical status classification: inter-observer consistency. American Society of Anesthesiologists. Anaesth Intensive Care 30:633–640

    CAS  PubMed  Google Scholar 

  18. Bassi C, Dervenis C, Butturini G et al (2005) International Study Group on pancreatic fistula definition: postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13

    Article  PubMed  Google Scholar 

  19. Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: 5-year experience. Ann Surg 250:187–196

    Article  PubMed  Google Scholar 

  20. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13715 carcinoid tumors. Cancer 97:934–959

    Article  PubMed  Google Scholar 

  21. Frilling A, Akestrom G, Falconi M et al (2012) Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer 19:R163–R185

    Article  CAS  PubMed  Google Scholar 

  22. Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3,851 patients. Ann Surg 247:490–500

    Article  PubMed  Google Scholar 

  23. Caplin ME, Pavel M, Cwikla JB et al (2014) Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 371:224–233

    Article  PubMed  Google Scholar 

  24. Modlin IM, Pavel ME, Kidd M, Gustafsson B (2010) Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumors. Aliment Pharmacol Ther 31:169–188

    CAS  PubMed  Google Scholar 

  25. Butturini G, Bettini R, Missiaglia E et al (2006) Predictive factors of efficacy of the somatostatin analogue octreotide as first-line therapy for advanced pancreatic endocrine carcinoma. Endocr Relat Cancer 13:1213–1221

    Article  CAS  PubMed  Google Scholar 

  26. Pavel M, Baudin E, Couverlard A et al (2012) ENETS Consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95:157–176

    Article  CAS  PubMed  Google Scholar 

  27. Larghi A, Capurso G, Carnuccio A et al (2012) Ki67 grading of non-functioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided-fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 76(3):570–577

    Article  PubMed  Google Scholar 

  28. Gaujoux S, Partelli S, Maire F et al (2013) Observational study of natural history of small sporadic non-functioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 98(12):4784–4789

    Article  CAS  PubMed  Google Scholar 

  29. Hirono S, Tani M, Kawai M et al (2009) A central pancreatectomy for benign or low-grade malignant neoplasms. J Gastrointest Surg. 13:659–665

    Article  Google Scholar 

  30. Pitt SC, Pitt HA, Baker MS et al (2009) Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Surg. 13:1692–1698

    Google Scholar 

Download references

Conflict of interest

The authors declare they all have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Pisa, Ospedale Cisanello, Via Paradisa 2, 56124, Pisa, Italy

    M. Lombardi, C. Sardella, D. Russo, C. Urbani, E. Martino, C. Marcocci & F. Bogazzi

  2. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

    N. De Lio & U. Boggi

  3. Department of Surgical, Medical and Molecular Pathology of Critical Area, University of Pisa, Pisa, Italy

    N. Funel & D. Campani

  4. Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council, Pisa, Italy

    G. Rossi

Authors
  1. M. Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. De Lio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Funel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Sardella
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Urbani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Campani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E. Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Marcocci
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. U. Boggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. F. Bogazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Lombardi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lombardi, M., De Lio, N., Funel, N. et al. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET. J Endocrinol Invest 38, 605–613 (2015). https://doi.org/10.1007/s40618-014-0219-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-014-0219-x

Keywords

Search

Navigation